About Scinovia
Scinovia is a company based in Durham (United States) founded in 2014. Scinovia has raised $6.91 million across 2 funding rounds. The company has 10 employees as of December 31, 2021. Scinovia offers products and services including Viewflow Platform and Hemodynamic Insight Tool. Scinovia operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Haermonics and i-sep, among others.
- Headquarter Durham, United States
- Employees 10 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Scinovia Corp
-
Annual Revenue
Not available
-
Net Profit
-$728.23 K (USD)0as on Dec 31, 2021
-
EBITDA
Not available
-
Total Equity Funding
$6.91 M (USD)
in 2 rounds
-
Latest Funding Round
$3.81 M (USD), Series A
Sep 12, 2022
-
Investors
Not available
-
Employee Count
10
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scinovia
Scinovia offers a comprehensive portfolio of products and services, including Viewflow Platform and Hemodynamic Insight Tool.
Platform for real-time blood flow monitoring in surgeries using AI.
Tool utilizing ML and AR for enhanced surgical data analysis.
People of Scinovia
Unlock access to complete
Unlock access to complete
Funding Insights of Scinovia
Scinovia has successfully raised a total of $6.91M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.81 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Scinovia
Investment portfolio details for Scinovia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scinovia
Detailed financials for Scinovia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scinovia Comparisons
Peer comparison for Scinovia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scinovia
Scinovia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Haermonics and i-sep, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hematology products and solutions are provided for medical applications.
|
|
| Locked | Locked | Locked |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
|
| Locked | Locked | Locked |
Intraoperative autotransfusion devices are developed and provided.
|
|
| Locked | Locked | Locked |
Postoperative pericardial drainage and flushing system is developed.
|
|
| Locked | Locked | Locked |
Cell salvage solutions for autologous blood transfusion during surgery
|
|
| Locked | Locked | Locked |
Develops medical devices for intraoperative blood recovery and conservation.
|
Detailed competitors of Scinovia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scinovia
Complete news archive for Scinovia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scinovia
Scinovia was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Scinovia is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Scinovia is a funded company, having raised a total of $6.91M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Scinovia is 10.
Scinovia was founded in 2014 in Durham, United States, within the medical technology sector. An augmented-reality-based imaging device is developed by the company to enable surgeons to visualize blood flow during procedures. This tool is applied in heart bypass, cardiovascular, plastic, and cancer removal surgeries, where real-time imaging assesses perfusion adequacy. Operations focus on surgical visualization enhancements for improved procedural outcomes.
Scinovia's top competitors include Haemonetics, VISIE and Sisu Global Health.
Scinovia offers Viewflow Platform and Hemodynamic Insight Tool.